CLOV vs CRBP · rev $1.37B vs $102.3M cap
Clover Health Investments Corp (CLOV) versus Corbus Pharmaceuticals Holding (CRBP) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CRBP revenue for 2022-12-31 was $0. Net income was -$42.3M. CRBP currently screens at market cap $102.3M.
CLOV currently screens at market cap $1.55B. CRBP currently screens at market cap $102.3M.
Not investment advice. Open the CLOV and CRBP stock pages for the full models.
Not investment advice.